Financials Abpro Bio Co., Ltd.

Equities

A195990

KR7195990007

Industrial Machinery & Equipment

End-of-day quote Korea S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
511 KRW -1.54% Intraday chart for Abpro Bio Co., Ltd. +4.07% -6.24%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 75,465 1,42,117 4,61,443 2,44,023 1,15,496 1,55,155
Enterprise Value (EV) 1 1,14,038 1,71,895 4,41,953 2,11,443 1,04,603 1,47,080
P/E ratio -5.63 x -2.94 x -6.28 x -22.3 x -13.9 x -5.89 x
Yield - - - - - -
Capitalization / Revenue 1.28 x 4.45 x 9.36 x 7.41 x 5.22 x 6.11 x
EV / Revenue 1.94 x 5.38 x 8.97 x 6.42 x 4.73 x 5.8 x
EV / EBITDA 7,775 x -6.69 x -556 x -78.1 x -10.7 x -17.7 x
EV / FCF -47.8 x -7.42 x 33.4 x -16.6 x -15.6 x -21.9 x
FCF Yield -2.09% -13.5% 2.99% -6.02% -6.42% -4.56%
Price to Book 0.72 x 1.1 x 3.32 x 1.83 x 0.82 x 1.27 x
Nbr of stocks (in thousands) 96,379 1,76,762 2,51,468 2,52,874 2,73,688 2,84,688
Reference price 2 783.0 804.0 1,835 965.0 422.0 545.0
Announcement Date 19/03/19 13/03/20 22/03/21 31/03/22 23/03/23 21/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 58,911 31,930 49,282 32,914 22,112 25,375
EBITDA 1 14.67 -25,686 -794.6 -2,708 -9,791 -8,305
EBIT 1 -5,985 -30,149 -8,043 -5,333 -11,193 -10,175
Operating Margin -10.16% -94.42% -16.32% -16.2% -50.62% -40.1%
Earnings before Tax (EBT) 1 -13,165 -34,923 -59,176 -9,675 -8,145 -25,658
Net income 1 -11,058 -35,694 -58,972 -10,030 -8,145 -25,742
Net margin -18.77% -111.79% -119.66% -30.47% -36.83% -101.44%
EPS 2 -139.0 -273.4 -292.1 -43.31 -30.36 -92.51
Free Cash Flow 1 -2,387 -23,160 13,227 -12,719 -6,719 -6,703
FCF margin -4.05% -72.53% 26.84% -38.64% -30.38% -26.41%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19/03/19 13/03/20 22/03/21 31/03/22 23/03/23 21/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 38,573 29,778 - - - -
Net Cash position 1 - - 19,491 32,581 10,893 8,075
Leverage (Debt/EBITDA) 2,630 x -1.159 x - - - -
Free Cash Flow 1 -2,387 -23,160 13,227 -12,719 -6,719 -6,703
ROE (net income / shareholders' equity) -10.6% -26.2% -47.9% -7.06% -5.87% -19.6%
ROA (Net income/ Total Assets) -2.15% -10.3% -2.73% -2% -4.31% -4.26%
Assets 1 5,14,933 3,46,100 21,63,952 5,02,446 1,88,914 6,04,657
Book Value Per Share 2 1,085 731.0 553.0 529.0 512.0 430.0
Cash Flow per Share 2 71.40 84.60 107.0 207.0 61.90 66.20
Capex 1 1,305 2,786 271 542 132 1,148
Capex / Sales 2.21% 8.73% 0.55% 1.65% 0.6% 4.53%
Announcement Date 19/03/19 13/03/20 22/03/21 31/03/22 23/03/23 21/03/24
1KRW in Million2KRW
Estimates
  1. Stock Market
  2. Equities
  3. A195990 Stock
  4. Financials Abpro Bio Co., Ltd.